Currax Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsCurrax Pharmaceuticals

Currax Pharmaceuticals

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Onzetra	Sumatriptan	2016-01-27	2024-2036	Migraine disorders , Cluster headache , Juvenile arthritis , Ankylosing spondylitis , Rheumatoid arthritis , Headache , Fever , Inflammation , Osteoarthritis , Bursitis , Back pain , Common cold , Toothache , Dysmenorrhea , Gout
Silenor	Doxepin	2010-03-17	2027-2030	Atopic dermatitis , Pruritus , Pain , Anxiety disorders , Psychotic affective disorders , Depressive disorder
Treximet	Naproxen, Sumatriptan	2008-04-15	2025-2026	Juvenile arthritis , Ankylosing spondylitis , Rheumatoid arthritis , Headache , Fever , Inflammation , Osteoarthritis , Bursitis , Back pain , Common cold , Toothache , Dysmenorrhea , Gout , Gastroesophageal reflux , Helicobacter infections , Duodenal ulcer , Zollinger-ellison syndrome , Esophagitis , Heartburn , Nausea , Sleep initiation and maintenance disorders , Allergic rhinitis perennial , Urticaria , Motion sickness , Sneezing , Anxiety disorders , Sinusitis , Asthma , Stomach ulcer , Migraine disorders , Cluster headache , Whooping cough , Bronchitis , Cough , Pharyngitis , Laryngitis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

migraine disorders

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use